SCHEMBL19862722

SCHEMBL19862722

c1ccc(-c2cc(-c3ccc(-c4c5ccccc5c(-c5ccc6c(c5)C5(c7ccccc7-c7ccccc75)c5ccccc5-6)c5ccccc45)cc3)cc(-c3ccccn3)c2)nc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 7/20 0.48
DHODH Q02127 1/20 0.34
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 1/20 0.33
CCR1 P32246 2/20 0.33
CCR5 P51681 2/20 0.33
CCR8 P51685 2/20 0.33
METAP1 P53582 2/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
BLM P54132 1/20 0.33
HIF1A Q16665 1/20 0.33
DOHH Q9BU89 1/20 0.33
P4HTM Q9NXG6 1/20 0.33
LRRK2 Q5S007 1/20 0.32
CYP2A6 P11509 1/20 0.32
TGFBR1 P36897 1/20 0.32
CNR2 P34972 1/20 0.32
NPY5R Q15761 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862717 0.93 PDK2 (0.44) PDK2DHODHKDM4ENPC1METAP1
SCHEMBL19862731 0.90 PDK2 (0.44) PDK2DHODHKDM4ENPC1CYP2A6
SCHEMBL19862721 0.88 PDK2 (0.46) PDK2DHODHKDM4ENPC1CYP1A2
SCHEMBL15198747 0.84 PDK2 (0.41) PDK2DHODHKDM4ENPC1CCR1
SCHEMBL19862729 0.84 PDK2 (0.41) PDK2DHODHKDM4ELMNACNR2
SCHEMBL16547405 0.84 PDK2 (0.38) PDK2DHODHLMNACYP1A2
SCHEMBL14580661 0.83 PDK2 (0.64) PDK2KDM4ENPC1CCR1CCR5
SCHEMBL15977727 0.83 PDK2 (0.47) PDK2DHODHCYP2A6CNR2NPY5R
SCHEMBL15198734 0.83 PDK2 (0.40) PDK2DHODHKDM4ENPC1CCR1
SCHEMBL21868015 0.82 PDK2 (0.56) PDK2DHODHKDM4ECCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190263735-A1 ORGANIC ELECTROLUMINESCENT DEVICE GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD . (CN) 2019-08-29 US disclosed
US-10347843-B2 Organic electronic material GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD. (CN) 2019-07-09 US disclosed
US-20180171218-A1 ORGANIC ELECTROLUMINESCENT DEVICE GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD . (CN) 2018-06-21 US disclosed
US-20180171218-A1 ORGANIC ELECTROLUMINESCENT DEVICE GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD . (CN) 2018-06-21 US disclosed
US-20180047909-A1 ORGANIC ELECTRONIC MATERIAL GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD . (CN) 2018-02-15 US disclosed
US-20180047909-A1 ORGANIC ELECTRONIC MATERIAL GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD . (CN) 2018-02-15 US disclosed
US-20180047910-A1 ORGANIC ELECTROLUMINESCENT DEVICE GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD . (CN) 2018-02-15 US disclosed
US-20180047910-A1 ORGANIC ELECTROLUMINESCENT DEVICE GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD . (CN) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180047909-A1 ORGANIC ELECTRONIC MATERIAL OCIAD1, OCIAD2, EED PDK2 3037/4885DHODH 729/4885KDM4E 2521/4885
US-20190263735-A1 ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, CTNND1 PDK2 2848/4885DHODH 668/4885KDM4E 3296/4885
US-10347843-B2 Organic electronic material OCIAD1, OCIAD2, EED PDK2 3037/4885DHODH 729/4885KDM4E 2521/4885
US-20180047910-A1 ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, CTNND1 PDK2 2912/4885DHODH 747/4885KDM4E 2575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.